$2.157
+0.146 (+6.77%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ATOS Prediction & Forecast by Similar Chart Analysis
Alphio's ATOS stock price prediction model matches the current Atossa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.16 (-0.05%). The 1-week path is $2.13 (-1.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Atossa Therapeutics Inc Stock?
Atossa Therapeutics Inc is not a good buy right now due to its current price of $2.1568, which is significantly below its 52-week high of $14.85, indicating a steep decline of 82.84% over the past year. Furthermore, the RSI is at 37.449, suggesting the stock is nearing oversold territory but has not yet shown signs of a reversal. The forward P/E ratio is 7.0423, which may seem attractive, but the company is experiencing substantial losses with a net income of -$9,589,000 in Q1 2026 and a gross profit of $0 in Q4 2024. The main risk is the company's ongoing financial struggles, as evidenced by a current ratio of 4.92, which, while still above 1, shows declining liquidity compared to previous quarters.
ATOS stock price ended at $2.16 on Friday, after rising +6.77%
Atossa Therapeutics Inc (ATOS) last closed at $2.1568, gaining +6.77%. These facts feed the 1-day and 1-week ATOS price prediction above.
Analyst Consensus
Atossa Therapeutics Inc (ATOS): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Atossa Therapeutics Inc (ATOS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ATOS, ranked by similarity.
Seasonality analysis for ATOS
Historically the probability of a positive November return for ATOS is 45.45%. October offers the highest probability of a positive month at 52.94%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ATOS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.93 | $1.02 | $1.03 | -52.87% |
| Dec 2026 | $0.77 | $0.88 | $0.99 | -59.25% |
In 2026, Atossa Therapeutics Inc (ATOS) is projected to range from $0.77 to $1.03.
Atossa Therapeutics Inc 2026 monthly forecast
In Nov 2026, Atossa Therapeutics Inc is projected to average $1.02, with a low of $0.93 and high of $1.03.
In Dec 2026, Atossa Therapeutics Inc is projected to average $0.88, with a low of $0.77 and high of $0.99.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.